Effects of eicosapentaenoic acid and docosahexaenoic acid on lipoproteins in hypertriglyceridemia
View Full Paper
Ask AI
Bookmark
Share
Key result
Prescription omega-3 fatty acids effectively lower triglyceride levels in patients with hypertriglyceridemia, with EPA-only preparations avoiding the LDL cholesterol increases seen with EPA/DHA combinations.
Why the study?
Do eicosapentaenoic acid and docosahexaenoic acid preparations improve lipoprotein profiles and prevent cardiovascular disease in patients with hypertriglyceridemia?
Population
Patients with hypertriglyceridemia (HTG) and high-risk patients for atherosclerotic disease
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
EPA-only omega-3 may be preferred for triglyceride lowering without LDL rise; leaves open outcome trials versus mixed formulations.
Structured PICO
Do eicosapentaenoic acid and docosahexaenoic acid preparations improve lipoprotein profiles and prevent cardiovascular disease in patients with hypertriglyceridemia?
P
Population
Patients with hypertriglyceridemia (HTG) and high-risk patients for atherosclerotic disease
I
Intervention
Prescription strength omega-3 fatty acid preparations (eicosapentaenoic acid [EPA] and docosahexaenoic acid [DHA])
O
Outcome
Effects on lipoproteins (triglyceride and low-density lipoprotein levels) and cardioprotective effects against vascular disease
Prescription-strength omega-3 fatty acids, particularly EPA preparations, effectively lower triglycerides without increasing LDL, and may offer protection against vascular disease in high-risk patients.
Limitations
- Cardiovascular outcome trials of omega-3 fatty acids have resulted in inconsistent results
- Long-term cardiovascular outcome studies for newer formulations are still underway
- Cardiovascular outcomes data are not fully available
- Long-term outcome studies are still underway
Cite This Study
Patel et al. (2016) conducted a review in Hypertriglyceridemia. Omega-3 fatty acids (EPA and DHA) was evaluated. Prescription omega-3 fatty acids effectively lower triglyceride levels in patients with hypertriglyceridemia, with EPA-only preparations avoiding the LDL cholesterol increases seen with EPA/DHA combinations.
View Full Paper
Ask AI
Bookmark
Share